2/5/2024 | CV | Market Commentary: Everbridge skyrockets on acquisition; solar stocks take a hit, Sunnova, Enphase lower
|
12/14/2021 | CV | Market Commentary: Luminar, Global Blood Therapeutics convertible offerings eyed; Everbridge improves
|
12/10/2021 | CV | Market Commentary: Lucid prices at discount, trades down; Everbridge tanks outright, expands on hedge
|
12/10/2021 | CV | Market Commentary: Morning Commentary: Lucid prices at discount, trades down; Everbridge tanks outright
|
3/11/2021 | CV | Everbridge greenshoe lifts 0% five-year convertibles to $375 million
|
3/9/2021 | CV | Market Commentary: BlackLine on tap; Vocera, Itron, Avid Bioservices eyed; Everbridge, Eventbrite trade up
|
3/9/2021 | CV | Market Commentary: Morning Commentary: Vocera, Itron, Avid Bioservices eyed; Everbridge, Eventbrite trade up
|
3/9/2021 | CV | New Issue: Everbridge prices upsized $325 million five-year convertible notes to yield 0%, up 40%
|
3/8/2021 | CV | Market Commentary: Vocera, Itron on deck; Everbridge; Eventbrite eyed; Airbnb improves; Enphase sinks further
|
3/8/2021 | CV | Market Commentary: Morning Commentary: Everbridge, Eventbrite eyed
|
3/8/2021 | CVLM | Everbridge to repurchase some of its outstanding 1.5% convertibles
|
3/8/2021 | CV | Everbridge talks $275 million five-year convertible notes to yield 0%, up 37.5% to 42.5%
|
2/19/2021 | CV | Market Commentary: GEO exchangeables trade up on debut; Expedia, MicroStrategy gain; Everbridge active
|
12/20/2019 | CV | Everbridge greenshoe ups 0.125% five-year convertibles to $450 million
|
12/11/2019 | CV | Market Commentary: Impinj convertible offering eyed; Everbridge convertible notes hit market; Lumentum up
|
12/11/2019 | CV | Market Commentary: Morning Commentary: Everbridge convertible notes hit the market; Impinj offering eyed
|
12/11/2019 | CV | New Issue: Everbridge prices $375 million five-year convertible notes to yield 0.125%, up 35%
|
12/10/2019 | CV | Market Commentary: Impinj on tap; Everbridge offering looks cheap; Western Asset prices; Lumentum below par
|
12/10/2019 | CV | Market Commentary: Morning Commentary: Everbridge offering eyed; Western Asset prices; Lumentum in focus
|
12/9/2019 | CV | Market Commentary: Everbridge, Western Asset on tap; market eyes Lumentum offering; existing notes contract
|
12/9/2019 | CV | Everbridge talks $375 million five-year convertible notes to yield 0%-0.25%, up 32.5%-37.5%
|
11/22/2017 | CV | Market Commentary: High trade volume for Intel continues; Everbridge, Square, Array make gains
|
11/20/2017 | CV | Everbridge greenshoe lifts 1.5% convertibles due 2022 to $115 million
|
11/16/2017 | CV | Market Commentary: Everbridge expands on debut, RH dominates trading, Quotient eclipses Rambus, Insulet active
|
11/16/2017 | CV | Market Commentary: Morning Commentary: Everbridge expands 3 points, Rambus up, Quotient hovers around par
|
11/16/2017 | CV | New Issue: Everbridge prices $100 million five-year convertible notes to yield 1.5%, up 25%
|
11/15/2017 | CV | Market Commentary: Rambus eclipses Quotient in trades; Everbridge to price; Emergent dips; Acorda tanks
|
11/15/2017 | CV | Market Commentary: Morning Commentary: Rambus, Quotient deals hit market, Everbridge in pipeline
|
11/14/2017 | CV | Market Commentary: Everbridge to price new deal, market awaits Rambus, Quotient; tech sector dominates trading
|
11/14/2017 | CV | Everbridge talks $100 million convertibles to yield 1.25% to 1.75%, up 22.5% to 27.5%
|
9/13/2016 | PP | Everbridge to price IPO of 6.25 million shares between $11.00, $13.00
|
8/19/2016 | PP | Everbridge registers $90 million stock for IPO, secondary offering
|